{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:30Z","timestamp":1792036290099,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fred A. & Barbara M. Erb Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bbadis.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T13:27:15Z","timestamp":1524317235000},"page":"2430-2437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest"],"prefix":"10.1016","volume":"1864","author":[{"given":"Stewart F.","family":"Graham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.04.012_bb0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0010","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0015","first-page":"210418","article-title":"Modulation at age of onset in tunisian Huntington disease patients: implication of new modifier genes","volume":"2014","author":"Hmida-Ben Brahim","year":"2014","journal-title":"Genet. Res. Int."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0020","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/nmt-2016-0008","article-title":"The global prevalence of Huntington's disease: a systematic review and discussion","volume":"6","author":"Baig","year":"2016","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neurobiolaging.2015.11.014","article-title":"Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome","volume":"38","author":"Pan","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","article-title":"Metabolic phenotyping in health and disease","volume":"134","author":"Holmes","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0045","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","article-title":"Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain","volume":"1862","author":"Graham","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.bbadis.2018.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/acs.jproteome.6b00049","article-title":"Novel metabolite biomarkers of Huntington's disease (HD) as detected by high resolution mass spectrometry","volume":"15","author":"Graham","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0055","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bbadis.2011.08.001","article-title":"(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease","volume":"1812","author":"Verwaest","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0060","doi-asserted-by":"crossref","first-page":"43030","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/pr900734g","article-title":"Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice","volume":"9","author":"Joyner","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0070","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/acn3.214","article-title":"A systems-level \"misunderstanding\": the plasma metabolome in Huntington's disease","volume":"2","author":"Rosas","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1039\/C4MT00223G","article-title":"Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status","volume":"7","author":"Kumar","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0080","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/elps.201500378","article-title":"Metabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools","volume":"37","author":"Pont","year":"2016","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study","volume":"13","author":"Paulsen","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0090","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1212\/WNL.50.1.252","article-title":"Frontal lobe volume in patients with Huntington's disease","volume":"50","author":"Aylward","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2010.07.002","article-title":"Complexity and pitfalls of mass spectrometry-based targeted metabolomics in brain research","volume":"406","author":"Urban","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/jp.2016.139","article-title":"Metabolomic profiling of brain from infants who died from sudden infant death syndrome reveals novel predictive biomarkers","volume":"37","author":"Graham","year":"2017","journal-title":"J. Perinatol."},{"issue":"7","key":"10.1016\/j.bbadis.2018.04.012_bb0110","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/acs.jproteome.7b00157","article-title":"Targeted metabolic profiling of post-mortem brain from infants who died from sudden infant death syndrome","volume":"16","author":"Graham","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11306-016-0957-1","article-title":"Identification of candidate biomarkers of brain damage in a mouse model of closed head injury: a metabolomic pilot study","volume":"12","author":"Bahado-Singh","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: an introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-60327-194-3_14","article-title":"Computational approaches to metabolomics","volume":"593","author":"Wishart","year":"2010","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0130","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0\u2014making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0135","doi-asserted-by":"crossref","first-page":"W127","DOI":"10.1093\/nar\/gks374","article-title":"MetaboAnalyst 2.0\u2014a comprehensive server for metabolomic data analysis","volume":"40","author":"Xia","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0140","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","article-title":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation","volume":"37","author":"Xia","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11306-016-1044-3","article-title":"Serum metabolomic markers for traumatic brain injury: a mouse model","volume":"12","author":"Bahado-Singh","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0022-510X(76)90114-3","article-title":"Morphometric studies of the neuropathological changes in choreatic diseases","volume":"28","author":"Lange","year":"1976","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.mam.2004.06.003","article-title":"Role of carnitine esters in brain neuropathology","volume":"25","author":"Virmani","year":"2004","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnutbio.2005.03.027","article-title":"Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes","volume":"17","author":"Calabrese","year":"2006","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1196\/annals.1344.013","article-title":"Mechanisms of ischemic neuroprotection by acetyl-L-carnitine","volume":"1053","author":"Zanelli","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression","volume":"5","author":"Pettegrew","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JHD-160189","article-title":"Delayed onset and reduced cognitive deficits through pre-conditioning with 3-Nitropropionic acid is dependent on sex and CAG repeat length in the R6\/2 mouse model of Huntington's disease","volume":"5","author":"Skillings","year":"2016","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","article-title":"Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders","volume":"106","author":"Farooqui","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbadis.2018.04.012_bb0200","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.89.5.1671","article-title":"Evidence for a membrane defect in Alzheimer disease brain","volume":"89","author":"Nitsch","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1471-4159.1998.70020786.x","article-title":"Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity","volume":"70","author":"Ross","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0210","first-page":"154","article-title":"Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MS","volume":"8","author":"Nasaruddin","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11881-V","article-title":"Brain polyamine levels are altered in Alzheimer's disease","volume":"197","author":"Morrison","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0225","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrn3839","article-title":"The molecular bases of the suicidal brain","volume":"15","author":"Turecki","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbadis.2018.04.012_bb0235","first-page":"14.10. 11","article-title":"Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis","author":"Xia","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918301443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918301443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T21:09:44Z","timestamp":1561928984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918301443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0925443918301443"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.04.012","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}